Case presentation

Dr. Mongiardi, Dr. Maresca: G.L. is a 64-year-old man on chronic oxygen therapy due to chronic obstructive pulmonary disease (COPD) in the setting of a bronchiectasic disease, referred to our hospital in September 2009 because of a micturition-nocturnal-syncope preceded by dizziness. The patient had neither a personal history of coronary artery disease nor known cardiovascular risk factors. In the emergency department (ED) the patient presented preserved consciousness and mild dyspnea despite low flows of inhalatory O2 (2 l/min); chest examination was characterized by sibilant and sonorous rales in addition to bibasilar thin crackles; hemo-gas analysis (HGA) showed severe hypoxemic-hypercapnic acidosis (pH 7.18, pCO2 85 mmHg, pO2 58 mmHg, sO2 84%, HCO3 23.5, 5); the ECG demonstrated sinus tachycardia, mild and non-specific ST segment elevation V1–V3; the chest X-ray study showed a COPD pattern, right-basal paracardiac radio-opacity, enlargement of the left cardiac chambers. Blood tests demonstrated a leukocytosis with a mild elevation of LDH and D-Dimer [WBC 19,860, Hb 13.4 g/dL, creatinine 0.85 mg/dL, troponin I (TI) 0.02 ng/mL, CPK e CPK-MB ns, D-Dimer 678 mg/dL, BNP 37 pg/mL]. In the ED, the patient was started on inhalatory salbutamol, furosemide, steroids and empiric i.v. antibiotic-therapy with piperacillin/tazobactam. An HGA executed 2 h later, documented resolution of the acidosis and of the hypoxia, clear reduction of the pCO2 (pH 7.4, pO2 70 mmHg, pCO2 55 mmHg, sO2 95%). In the afternoon, the patient was transferred to the department of Internal Medicine. About 1 h after admission, he presented sudden, severe shortness of breath and diaphoresis, the ECG demonstrated sinus tachycardia, a new onset of mild ST segment elevation V3–V6; an HGA showed severe respiratory hypoxic-hypercapnic acidosis (pH 7.16 pCO2 91 mmHg, pO2 56 mmHg, sO2 79%). IV steroids and inhaled salbutamol were again administered with subsequent resolution of the dyspnea and improvement of gas exchange. Blood tests revealed a mild, initial increase of TI (0.77 ng/mL at time 0 min, 0.17 ng/mL 6 h later) with persistently normal LDH, AST, and CK. The ECG presented giant and symmetrical negative T-waves in inferior-lateral derivations (D1–D3, V4–V6).

Preliminary diagnosis

Dr. Squizzato, Prof. Ageno: After cardiologic consultation, on the basis of the ECG abnormalities and a positive marker for myocardial necrosis, therapy with ASA, nitrates and a therapeutic dose of low molecular weight heparin was started. The cardio-thoracic examination was unchanged. A trans-thoracic echocardiogram revealed a mild eccentric left ventricular hypertrophy; a well-preserved global and segmentary wall-motion (ejection fraction 60%); an altered diastolic function with a pseudo-normalized pattern at color-Doppler and tissue-Doppler-imaging; an absence of tricuspidal regurgitation and a normal systolic pulmonary artery pressure; a high-resistance Doppler flow pattern in the first tract of pulmonary artery and, finally, a mildly enlarged inferior vena cava with preserved collapse during inspiration. An angio-computed tomography scan was performed, and demonstrated a filling defect of the left pulmonary artery at the bifurcation between upper and inferior branches compatible with acute pulmonary embolism (PE) (Fig. 1). A subsequent ECG showed inferior–lateral ischemic alterations accompanied by ST segment-depression V4–V5 suggestive of an acute coronary syndrome (ACS).

Fig. 1
figure 1

Angio-computed tomography scan demonstrates filling defect of the left pulmonary artery (LPA) at the bifurcation between upper and inferior branches compatible with acute pulmonary embolism

Definitive diagnosis

Dr. Verna, Dr. Bertolini: A few days later, the patient underwent coronary angiography that revealed the presence of a coronary arterial fistula (CAF) originating from the proximal circumflex coronary artery (the caliber of the aberrant lumen was 5 mm) at high-flow with an extended vascular network projecting to the left atrium and opacifying the inferior left pulmonary lobar branches (Fig. 2). The same peripheral artery appeared at this direct angiogram to be involved with an intraluminal filling defect compatible with a peripheral result of pulmonary embolism (Fig. 3). Selective intra-operatory oxymetry demonstrated an increase in oxygen-saturation of the left pulmonary artery as a further proof of the communication through the fistula. After 5 days, a second coronary angiography was performed, and an Amplatzer® Vascular-Plug-VP4 (8 mm) was placed at the in-flow tract of the CAF. Subsequent angiographic control at 24 h demonstrated a correct placement and regular expansion of the device with minimal residual aberrant flow through the device. The patient was discharged on oral anticoagulant therapy with vitamin K antagonists, and had no further complications at a 3-month follow-up. The final diagnosis was acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism.

Fig. 2
figure 2

Coronarography revealed the presence of CAF originating from the proximal circumflex coronary artery (the caliber of the aberrant lumen was 5 mm) at high-flow with extended vascular network (arrows on the left) projecting to the left atrium and opacifying the inferior left pulmonary lobar branches

Fig. 3
figure 3

Direct angiogram showed at the peripheral tract of left pulmonary artery’s (LPA) inferior branch the presence of filling defect compatible with peripheral result of pulmonary embolism

Discussion

Prof. Venco, Dr. Mongiardi, Dr. Dentali: Acute coronary syndromes (ACS) include a group of clinical conditions caused by myocardial ischemia, namely unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). Appropriate and accurate diagnosis has life-saving implications, and requires a quick, but thorough evaluation of the patient history, physical examination, electrocardiogram, and cardiac biomarkers [1].

Coronary arterial fistula (CAF) is a connection between one or more of the coronary arteries and a cardiac chamber or a great vessel [2]. The incidence of CAF is unknown, but it has been reported to represent an incidental finding in 0.1–0.2% of coronary angiograms [3]. The majority of these fistulas are congenital, although they may also occur as a complication of cardiac surgery. In the first two decades of life, they are usually asymptomatic, and a small number of them may close spontaneously [4]. In older subjects, the frequency of CAF-related complications increases, including rupture, thrombosis and embolism of the fistula, dysrhythmias, endocarditis/endarteritis, and, more rarely, congestive cardiac failure and a steal syndrome from the adjacent myocardium [58].

In this case report, we describe a steal syndrome from the coronary flow that was attributed to an acquired condition such as an acute PE in a patient with a congenital, asymptomatic CAF.

We hypothesize that the presence of the PE, upstream of the fistula’s outflow in the pulmonary artery, determined a redistribution of the pressure gradients between coronary and peripheral pulmonary circulation provoking the ACS. This hypothesis is further supported by the absence of atherosclerotic lesions in the coronary arteries.

The clinical presentation of our patient was rather atypical. Hypercapnia, leucocytosis, and chest X-ray findings may be secondary to an exacerbation of COPD. Conversely, the initial syncopal episode and the in-hospital recurrence of sudden respiratory failure despite appropriate therapy for exacerbation of a COPD were suggestive of an episode of acute PE. COPD is associated with an increased risk for PE [9]. ACS is an uncommon complication in patients with an acute episode of PE. In our case report, the finding of embolization upstream of the fistula’s outflow in the pulmonary artery was believed to explain this strange presentation.

Until recently, surgery was the routine treatment for CAFs. Nowadays, transcatheter closure is recommended using a variety of devices, such as occlusion coils, vascular plugs, umbrella devices and covered stents [4, 1013]. Vascular plugs are generally well tolerated and complications are extremely rare. Due to the concomitant presence of PE, our patient was managed with both anticoagulant therapy and with the placement of an Amplatzer® Vascular-Plug-VP4. In general, secondary prevention of ACS includes antiplatelet therapy. However, in our patient coronary angiography did not reveal any significant abnormality beyond the CAF. Thus, treatment with antiplatelet therapy did not appear to be indicated for the secondary prevention of cardiovascular events in our patient. Acute treatment with low molecular weight heparin followed by oral anticoagulation is the mainstay therapy of PE. In this specific case, it seems reasonable that anticoagulation is an effective treatment also to reduce the risk of ACS recurrence since ACS appeared to be due to the coronary-pulmonary steal syndrome.